Approval

Options Smart Investment Report: Novo Nordisk's call order surges over 8 times; oral weight loss drug receives FDA approval.

I. Overview of US Stock Index Options Trading volume in the US stock index options market is currently declining, and t...

Stock
2026-01-12
Options Smart Investment Report: Novo Nordisk's call order surges over 8 times; oral weight loss drug receives FDA approval.

US pharmaceutical giants find themselves in a passive position as the government ignores lobbying efforts and continues to ease approval requirements for generic drugs.

The U.S. government announced on Wednesday that it will expedite the approval process for complex biosimilars and relax...

Stock
2026-01-12